Singapore – English
Performance beyond imagination.
Together with leading clinicians worldwide, Straumann has put to the test the SLActive® surface under the most challenging medical conditions and treatment protocols to demonstrate the extensive healing potential of SLActive®. This showed outstanding clinical performance even in severely compromised patients. Discover how you can benefit from high-performance SLActive® implants to support your patients’ healing capabilities.
Irradiated patients
In a randomized clinical trial, SLActive® implants in irradiated patients showed a success rate of 100% after 1-year1 and 5-year2, 3 follow-ups.
Diabetic patients
Clinical evidence shows the high predictability of SLActive® in diabetic patients.4
Compromised treatment sites
In a recent preclinical study5, SLActive® showed significantly higher formation of new bone aggregate within eight weeks compared to the standard Straumann® SLA® surface.
Brochures and videos
Looking for additional information? You'll find them in the Download Center.